Recent Updates
Recently added Catalysts
BBIO

BridgeBio Pharma Appoints Sanuj Ravindran, M.D., And Eric Michael David, M.D. As CEOs-in-Residence To Lead Dermatology And Gene Therapy Programs

Thursday, January 4, 2018 1 min read
Key Takeaway: BridgeBio Pharma Appoints Sanuj Ravindran, M.D., And Eric Michael David, M.D. As CEOs-in-Residence To Lead Dermatology And Gene Therapy Programs

Full Press Release Details

BridgeBio Pharma Appoints Sanuj Ravindran, M.D., And Eric Michael David, M.D. As CEOs-in-Residence To Lead Dermatology And Gene Therapy Programs.
Tags: BBIO Viatris Investor Conferences Healthcare investor conferences healthcare conferences UBS Global Healthcare
Last updated: Jan 4, 2018